Concerning allergic diseases, the incidence of allergic symptoms, as well as their severity, seems to decrease with age. The decline of onset of allergic symptoms observed in ageing might result from a decrease of serum total and specific IgE. Atopic disorders are complex diseases that involve interactions among several physiological systems, e.g. skin, lung, mucosae, and the immune system. It was the aim of this study to compare the effects of age on total and specific IgE in patients with atopic dermatitis (AD), allergic rhinitis or asthma, and insect allergy, respectively.
Introduction
Concerning allergic diseases, the incidence of onset of allergic symptoms, as well as their severity seems to decrease with age [1] . Atopy is a relatively common, adverse humoral immune system response to common environmental agents (allergens) involving the production of allergen-specific IgE. Epidemiological investigations of allergen sensitivity in a community-based population [2] [3] [4] [5] and an industrial setting [6, 7] show that the propensity for and the relative incidence of atopic disorders tend to change with age. Serum total IgE values decline with age in the general population, and there are significantly fewer cases of atopy among elderly subjects (60 years and older) compared with younger subjects. However, atopic disorders are complex diseases that involve interactions among several physiological systems, e.g. skin, lung, mucosae, and the immune system.
The immune system undergoes characteristic changes with ageing. Most tests of T cell function are depressed in elderly individuals and the deterioration of the immune systems is believed to contribute to morbidity and mortality in man [8] .
Age-associated alterations in the proportions of T cell subsets have been well documented in humans. There are clearly more CD4+ CD45RO+ "memory-phenotype" cells and less CD45RA+ "naïve-phenotype" cells in peripheral blood mononuclear cells (PBMC) from elderly individuals. The accumulation of CD45RO+ memory cells results in a reduced ability to respond to new antigens, and a retained ability to respond to recall antigens, as long as the memory cells remained present and functional [9] [10] [11] .
Data on age-associated alterations in cytokine secretion in human are inconsistent. Th1 cells are characterised by their ability to secrete IFNγ, IL-2, TNF-α, IL-12 and IL-15, whereas Th2 cells are characterised by IL-4, IL-5, IL-6, IL-10 and IL-13 secretion. Infant humans exhibit impaired cellular but strong humoral immunity, and are in a type 2dominant state. Soon thereafter, a type 1-state becomes dominant and persists in healthy humans until mid-tolater life, at which time a dominant type 2 cytokine profile may again emerge [12] . Paradoxically, despite declining T cell function, ageing does nor appear always to be associated with decreased immune reaction. For instance, there are increased levels of autoantibodies in the aged [13] , resulting in autoimmune diseases (e.g. bullous pemphigoid).
Current thought posits that age-associated changes in Bcell function are primarily due to changes in the T-cell compartment and a resultant dysregulation on B-cell function [14] . Altered function is primarily associated with exposure to "new" antigenic challenges, as for example the less efficient therapeutic value of inoculation regimes among the elderly population. Although both T cells and B cells are involved with the onset of atopy, the effector mechanisms are principally humorally driven and focused on the production and regulation of IgE. To what extent this regulation is T cell dependent or T cell independent is not well stablished. Recently, it has been demonstrated that in healthy non-atopic individuals no differences in either serum total IgE and soluble CD23 or Th2 related cytokines (IL-4, IL-10 and IL-13) between young and old subjects were observed [15] .
However, there are not many studies investigating the relationship between age and IgE in different atopic diseases. In this study, we evaluated the effects of age on total and specific IgE in patients with atopic dermatitis (AD), allergic rhinitis or asthma, and insect allergy.
Methods

Study population
The population of this retrospective study consisted of 559 individuals (male: 229 and female: 330) randomly selected from a data bank of patients diagnosed for one of the relevant diseases. The diagnoses were made on the basis of the case history and the clinical examination. Total and/or allergen specific IgE was measured in every individual. From the whole study population, 113 patients suffered from AD, 132 had allergic rhinitis or asthma, and 314 were tested because of insect allergy.
Determination of serum IgE
Total and allergen specific serum IgE was measured by using the UniCAP System (Pharmacia, Freiburg, Germany) according to the instructions of the manufacturer. Directly after collection of venous blood, the blood was centrifuged and serum was stored at -20°C until testing. Total serum IgE levels < 300 kU/l are in the normal or borderline range, amounts ≥ 300 kU/l were classified as pathological [17] . Serum IgE specific was determined at least for one of the following antigens: Dermatophagoides pteronyssinus and farinae (Der p 1 and Der f 1), Betula verrucosa (Bet v 1), Phleum pratense (Phl p 1), Felis domesticus (Fel d 1), and hymenoptera venoms. In patients with allergic asthma or rhinitis and in patients with AD Der p 1 and Der f 1, Bet v 1, Phl p 1, and Fel d 1 were measured. In patients with insect allergy specific IgE to hymenoptera venoms was tested. For patients polysensitized against several allergens, the highest value of specific IgE was selected and only this value was used for statistical analysis.
Statistical analysis
Statistical analysis for paired comparisons of total and specific IgE between different patient groups was conducted by Student's t test. In order to assess the relationship between IgE and age, we calculated Kendall's tau-b and the corresponding p-values to test the hypothesis that both variables are not associated [18] . Additionally, we used simple linear regression to evaluate age-associated changes in serum IgE. Statistical analysis was performed by using the software program SPSS 9.0.
Results
Patients characteristics
The study population consisted of 559 patients suffering from either AD (n = 113), allergic asthma or rhinitis (n = 132) or insect allergy (n = 314) tested for total and specific serum IgE (Table 1) . Mean age of patients with AD was 23.5 years, whereas mean age of the patients with allergic rhinitis, asthma or insect allergy was 36.7 years and 44.2 years, respectively ( Table 1 ). In the group of patients > 65 year old 6 (5.3%) had AD, 24 (18.2%) sufferd from rhinitis or asthma, and 105 (33.4%) from insect allergy. Twentytwo patients with insect allergy were younger than 10 years. In the group of patients with insect allergy older than 65 years the onset of symptoms was always over 60 years but not in the group of patients with AD and allergic rhinitis or asthma where symptoms onset always started earlier. Independent of age, the highest amounts of total and specific IgE ( Figure 1 ) were found in patients with AD compared with the other patient groups (p < 0.01; p < 0.02).
Ageing and total serum IgE
The total IgE had a negative correlation (p < 0.0001) with age in all patients as well as in the subgroups of patients with allergic rhinitis and asthma, and insect allergy. In contrast, no significant decrease of total serum IgE as a function of age was observed in patients with AD (Table  1 ). Figure 2 shows the values of total serum IgE (kU/l) against donors age for patients with AD, allergic asthma or rhinitis, and for insect allergy. For patients with allergic asthma and rhinitis (F (1,130) = 10.850, p = 0.001) as well as for patients with insect allergy (F (1,307) = 16.236, p <0.0001), the slopes of the lines derived from simple linear regression do vary significantly from zero, but do not for patients with AD (F (1,110) = 1,734, p = 0.191).
Additionally, in the group of patients with a total IgE < 300 kU/l a reduction of total serum IgE was significantly correlated with age (p <0.0001). In contrast, patients with IgE levels > 300 kU/l showed no correlation with age ( Table 2) . From the patients with IgE levels > 300 kU/l, 16 (11.9%) were over 65 years old. Linear regression analysis revealed F (1,400) = 20.955 (p <0.0001) for total IgE levels < 300 kU/l but were not significant for IgE levels > 300 kU/ l (F (1,149) = 1,138, p = 0.288) Figure 1 shows specific IgE values for each tested allergen in the different disease groups. No significant differences of mean IgE values between the different allergens could be detected except in patients with insect allergy. In patients with insect allergy only wasp and bee allergen were tested and the mean specific IgE for bee was significantly (p = 0.02) lower compared with wasp specific IgE. The majority of these patients (91.7%) had immunotherapy because of wasp allergy, whereas 8.3% had immunotherapy because of clinical relevant sensitization (Table  3 ). In patients with atopic dermatitis or with rhinitis/allergic asthma relevant sensitization (0.35 kU/l) against the different allergens was distributed homogenously. Only sensitization to Fel d 1 was less frequent in patients with allergic rhinitis or asthma (Table 3 ).
Ageing and allergen specific IgE
Allergen specific IgE was significantly decreased in the elderly suffering from allergic rhinitis, allergic asthma (p < 0.0001) and insect allergy (p = 0.029), respectively. On the other hand, no correlation between specific IgE and age was observed in patients with AD (Table 1) .
For patients with allergic asthma and rhinitis (F (1,130) = 26.437, p = 0.0001) the slopes of the lines derived from simple linear regression do vary significantly from zero ( Figure 2 ). For patients with insect allergy (F (1,308) = 0.110, p = 0.740) and for patients with AD (F (1,68) = 0,283, p = 0.596), linear regression did not reveal significant variation from zero for allergen specific IgE (Figure 2 ).
Discussion
From a clinical perspective, supported by epidemiological investigations, there would appear to be a decline with age in both the incidence and severity of atopic diseases, particularly among the elderly population who are 60 years and older [2] [3] [4] [5] [6] [7] . Atopic incidence declines, symptoms severity declines, and there would appear to be a general humoral alteration of the propensity for atopy reflected by age-associated declines in serum total IgE values. However, the results of this study demonstrate that the association between age and serum IgE is dependent on the type of atopic or allergic disease and is also dependent on the amount of total serum IgE.
The results of our study are supported by data that have been published recently by Jackola et al. [16] . In patients with allergic asthma they observed a decline with age in serum total IgE values. Moreover, they showed that among those asthmatic individuals sensitized to ragweed antigen, there was no age-associated change in IgE levels specific to the major ragweed allergen. This robustness of the underlying atopic mechanism, represented by specific IgE was also observed in our patients with AD but not in the patients with allergic asthma or rhinitis and in patients with insect allergy. Concerning insect allergy, this difference might be partly explained by the later onset of sensitization against hymenoptera venoms during life and thus, other immunological mechanisms regulating the production of specific IgE in patients with insect allergy, which has been defined as hypersensitivity allergic nonatopic IgE-mediated disease [17] . This assumption is supported by the fact that in the group of patients with insect allergy older than 65 years the onset of symptoms was always over 60 years but not in the group of patients with AD and allergic rhinitis or asthma.
The differences according age-association of allergen-specific IgE in patients with asthma between the two studies might be the consequence of patient's selection. The subgroup of patients with asthma in our study probably was more heterogenous compared with the population investigated by Jackola and co-workers. Moreover, it is not clear whether asthma patients with additional manifestations of other atopic diseases (e.g. AD or rhinitis) were excluded in their study or not.
As expected, the numbers of patients with AD older than 60 years were rather small. However, a higher proportion of AD patients were over 40 years old indicating that in this group of adults IgE production is unaffected by age.
The results of our study support the assumption that ageassociation of total and specific serum IgE is dependent on the type of atopic disease the patients are suffering from and the age at disease onset.
Conclusion
In summary, this study shows that total and allergen specific IgE production is reduced in the elderly with the exception of old patients with either high serum IgE or AD, indicating that atopic mechanisms underlying AD or other atopic diseases with high serum IgE are particularly robust, and the atopic propensity among these patients remains into advanced age. However, further studies are required to clarify the immunological mechanisms which are responsible for IgE synthesis during immunosenscence.
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